Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF208 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SCUBE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FSTL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C10orf67 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TNXB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTCH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TRUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARGE-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ONECUT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBP15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF292 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AAK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLFN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on